An Open-label, Dose Escalation, Pharmacodynamic, Pharmacokinetic, and Effect of Food Phase 1 Study of E7820 to Determine the Maximum Tolerated Dose Following Twice Daily Oral Administration in Subjects With Unresectable Solid Tumors
Clinical trial NCT01773421 · COMPLETED
Trial details
- NCT number
- NCT01773421
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-30
- Primary completion
- 2014-04-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.